D. Welzel

2.0k total citations
68 papers, 1.1k citations indexed

About

D. Welzel is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, D. Welzel has authored 68 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 15 papers in Internal Medicine and 8 papers in Surgery. Recurrent topics in D. Welzel's work include Venous Thromboembolism Diagnosis and Management (15 papers), Blood Pressure and Hypertension Studies (11 papers) and Atrial Fibrillation Management and Outcomes (8 papers). D. Welzel is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (15 papers), Blood Pressure and Hypertension Studies (11 papers) and Atrial Fibrillation Management and Outcomes (8 papers). D. Welzel collaborates with scholars based in Germany, Japan and United States. D. Welzel's co-authors include J. D. Ringe, Gottfried Weidinger, L. Färber, Matthias Bräutigam, Ulrich Mrowietz, H. Kaiser, Enno Christophers, Hans Wolf, H.C. Hemker and Susanne Alban and has published in prestigious journals such as Stroke, Journal of Allergy and Clinical Immunology and Hypertension.

In The Last Decade

D. Welzel

65 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Welzel Germany 19 300 221 166 166 122 68 1.1k
Rosalia Lo Presti Italy 20 298 1.0× 39 0.2× 165 1.0× 245 1.5× 67 0.5× 161 1.6k
A. Tucker United Kingdom 17 209 0.7× 86 0.4× 240 1.4× 27 0.2× 37 0.3× 34 873
MJ Adams Australia 19 184 0.6× 175 0.8× 111 0.7× 124 0.7× 31 0.3× 68 1.1k
Myron Mavrikakis Greece 25 809 2.7× 17 0.1× 298 1.8× 215 1.3× 90 0.7× 65 1.9k
Salome Kristensen Denmark 16 137 0.5× 42 0.2× 110 0.7× 43 0.3× 65 0.5× 75 857
Baldassare Canino Italy 15 186 0.6× 39 0.2× 95 0.6× 213 1.3× 20 0.2× 85 1.0k
J Gélin Sweden 22 142 0.5× 25 0.1× 352 2.1× 291 1.8× 93 0.8× 46 2.0k
Stephen Yu United States 22 114 0.4× 85 0.4× 902 5.4× 147 0.9× 64 0.5× 41 1.5k
Ömer Özcan Türkiye 21 380 1.3× 18 0.1× 298 1.8× 173 1.0× 35 0.3× 65 1.4k
Giuseppe Coppola Italy 23 1.0k 3.4× 104 0.5× 433 2.6× 331 2.0× 29 0.2× 82 1.9k

Countries citing papers authored by D. Welzel

Since Specialization
Citations

This map shows the geographic impact of D. Welzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Welzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Welzel more than expected).

Fields of papers citing papers by D. Welzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Welzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Welzel. The network helps show where D. Welzel may publish in the future.

Co-authorship network of co-authors of D. Welzel

This figure shows the co-authorship network connecting the top 25 collaborators of D. Welzel. A scholar is included among the top collaborators of D. Welzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Welzel. D. Welzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alban, Susanne, D. Welzel, & H.C. Hemker. (2002). Pharmacokinetic and Pharmacodynamic Characterization of a Medium-Molecular-Weight Heparin in Comparison with UFH and LMWH. Seminars in Thrombosis and Hemostasis. 28(4). 369–378. 14 indexed citations
2.
Shafi, Shahida, et al.. (2000). Effect of Reserpine Treatment on Low-Density Lipoproteins in Arterial Wall and Internal Organs of Rats. Journal of Cardiovascular Pharmacology. 35(5). 686–692. 4 indexed citations
3.
4.
Griebenow, R., David Pittrow, Gottfried Weidinger, et al.. (1997). Low-dose Reserpine/Thiazide Combination in First-line Treatment of Hypertension: Efficacy and Safety Compared to an ACE Inhibitor. Blood Pressure. 6(5). 299–306. 12 indexed citations
5.
6.
Vane, John R., Gustav V. R. Born, & D. Welzel. (1995). The endothelial cell in health and disease. 18 indexed citations
7.
Griebenow, R., Ralf Müller, Hans‐Michael Steffen, Klaus J. Burger, & D. Welzel. (1993). Effect of Short-Term Antihypertensive Therapy on Left Ventricular Wall Tension A Double-Blind Comparison of Isradipine and Nifedipine. American Journal of Hypertension. 6(3_Pt_2). 92S–94S. 1 indexed citations
8.
Welzel, D., et al.. (1993). [Circadian antihypertensive action and tolerability of a sustained-release form of isradipine in an intra-individual comparison with nitrendipine].. PubMed. 43(5). 522–5. 5 indexed citations
9.
Przuntek, H., et al.. (1992). Primary Combination Therapy of Early Parkinson’s Disease. European Neurology. 32(1). 36–45. 10 indexed citations
10.
Wolf, Helmut, et al.. (1991). Comparison of the Efficacy and Safety of Sandoz Low Molecular Weight Heparin and Unfractionated Heparin: Interim Analysis of a Multicenter Trial. Seminars in Thrombosis and Hemostasis. 17(4). 343–346. 14 indexed citations
11.
Welzel, D. & Klaus J. Burger. (1990). The Calcium Antagonist Isradipine in the Therapy of Hypertension. Drugs. 40(Supplement 2). 60–64. 9 indexed citations
12.
Kakkar, Vijay V., Mark D. Stringer, Chris Parker, et al.. (1989). Fixed combinations of low-molecular weight or unfractionated heparin plus dihydroergotamine in the prevention of postoperative deep vein thrombosis. The American Journal of Surgery. 157(4). 413–418. 24 indexed citations
13.
Gulba, Dietrich C., Klaus Fischer, M. Barthels, et al.. (1989). Low dose urokinase preactivated natural prourokinase for thrombolysis in acute myocardial infarction. The American Journal of Cardiology. 63(15). 1025–1031. 14 indexed citations
14.
Dominiak, Peter, Joachim Grevel, E. Abisch, et al.. (1988). The absolute systemic availability of a new oral formulation of co-dergocrine in healthy subjects. European Journal of Clinical Pharmacology. 35(1). 53–57. 3 indexed citations
15.
Trübestein, G, et al.. (1987). Effects of Pro-Urokinase and Urokinase on the Fibrinolytic System in Man. Pathophysiology of Haemostasis and Thrombosis. 17(4). 238–244. 7 indexed citations
16.
Ringe, J. D. & D. Welzel. (1987). Salmon calcitonin in the therapy of corticoid-induced osteoporosis. European Journal of Clinical Pharmacology. 33(1). 35–39. 114 indexed citations
17.
Welzel, D., et al.. (1982). [Co-dergocrinmesylate in elderly hypertensive patients].. PubMed. 124(48). 1095–8. 4 indexed citations
18.
Shand, David G., Michael R. Hall, Stephen H. Buck, et al.. (1982). Opening Remarks by Prof. M. Bergener, Köln. Gerontology. 28(1). 1–4. 3 indexed citations
19.
Rosenthal, J, F. Escobar‐Jiménez, Rainer Lang, et al.. (1978). [A field study with the combination of Pindolol and Clopamid in antihpertensive therapy (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 73(42). 1481–6. 1 indexed citations
20.
Welzel, D., et al.. (1977). [Quantitative assessment of drug-induced prophylaxis of postoperative thromboembolism. Comparison of frequencies of deep vein thrombosis and pulmonary embolism using acetylsalicylic-acid, dextran, dihydroergotamine, low-dose heparin and the fixed combination of heparin and dihydroergotamine (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 72(40). 1624–38. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rosalia Lo Presti Breakdown of academic impact, for papers by A. Tucker Breakdown of academic impact, for papers by MJ Adams Breakdown of academic impact, for papers by Myron Mavrikakis Breakdown of academic impact, for papers by Salome Kristensen Breakdown of academic impact, for papers by Baldassare Canino Breakdown of academic impact, for papers by J Gélin Breakdown of academic impact, for papers by Stephen Yu Breakdown of academic impact, for papers by Ömer Özcan Breakdown of academic impact, for papers by Giuseppe Coppola
Rankless by CCL
2026